Pharmacologic Targets and Peritoneal Membrane Remodeling | Zendy

Farhat Karima | Zendy; Stavenuiter Andrea W.D. | Zendy; Beelen Rob H.J. | Zendy; ter Wee Piet M. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacologic Targets and Peritoneal Membrane Remodeling

Author(s) -

Farhat Karima,

Stavenuiter Andrea W.D.,

Beelen Rob H.J.,

ter Wee Piet M.

Publication year - 2014

Publication title -

peritoneal dialysis international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.79

H-Index - 83

eISSN - 1718-4304

pISSN - 0896-8608

DOI - 10.3747/pdi.2011.00332

Subject(s) - peritoneal dialysis , medicine , endogeny , peritoneum , pathology

Peritoneal dialysis (PD) is associated with functional and structural changes of the peritoneal membrane, also known as peritoneal remodeling. The peritoneal membrane is affected by many endogenous and exogenous factors such as cytokines, PD fluids, and therapeutic interventions. Here, we present an overview of various studies that have investigated pharmacologic interventions aimed at regression of peritoneal damage and prolongation of PD treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research